Raphael Pharmaceutical (RAPH) Market Capitalization (2023 - 2026)

Raphael Pharmaceutical has disclosed Market Capitalization across 4 years of filings, most recently posting $28.2 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 91.9% year-over-year to $28.2 million; the TTM figure through Jun 2026 stood at $28.2 million (up 91.9% YoY), while the FY2025 annual figure was $28.2 million, up 480.93% from the prior year.
• Market Capitalization came in at $28.2 million for Q2 2026 at Raphael Pharmaceutical, roughly flat from $28.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $30.9 million in Q2 2024 to a low of $4.9 million in Q4 2024.
• Average Market Capitalization over 4 years is $20.1 million, with a median of $18.7 million recorded in 2024.
• The largest YoY upside for Market Capitalization was 480.93% in 2025 against a maximum downside of 74.56% in 2025.
• Over 4 years, Market Capitalization stood at $18.5 million in 2023, then plunged by 73.72% to $4.9 million in 2024, then jumped by 480.93% to $28.2 million in 2025, then changed by 0.0% to $28.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $28.2 million in Q2 2026, $28.2 million in Q4 2025, and $7.9 million in Q3 2025.